Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics

• Prif Awduron: Anastasiia S. Boiko (Awdur), Irina A. Mednova (Awdur), Elena G. Kornetova (Awdur), Valeria I. Gerasimova (Awdur), Alexander N. Kornetov (Awdur), Anton J. M. Loonen (Awdur), Nikolay A. Bokhan (Awdur), Svetlana A. Ivanova (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2021-05-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The present study aims at comparing the change in cytokine levels in schizophrenia patients treated with atypical antipsychotics, with or without metabolic syndrome (MetS). The study included 101 patients with schizophrenia, 38 with and 63 without MetS, who received risperidone, quetiapine, olanzapi...